Calcium Gluconate Administration for Hyperkalemia in the Emergency Department
Immediate Indications for Calcium Administration
Administer IV calcium gluconate immediately if the patient has any ECG changes (peaked T waves, widened QRS, prolonged PR interval, flattened P waves) OR serum potassium ≥6.5 mEq/L, regardless of symptoms. 1, 2 Calcium does NOT lower potassium—it only stabilizes cardiac membranes temporarily for 30–60 minutes while other therapies take effect. 1, 3
Standard Dosing Protocol
Adults
- Calcium gluconate 10%: 15–30 mL IV over 2–5 minutes with continuous ECG monitoring 1, 2, 4
- Alternatively, calcium chloride 10%: 5–10 mL (500–1000 mg) IV over 2–5 minutes if central venous access is available, as it provides more rapid ionized calcium increase 1, 2
Pediatrics
- Calcium gluconate: 100–200 mg/kg/dose via slow IV/IO infusion with continuous ECG monitoring 2
- Calcium chloride: 20 mg/kg (0.2 mL/kg of 10% solution) is preferred for critically ill children when central or IO access is obtained 5, 2
Administration Routes and Access
Only IV or intraosseous (IO) routes are effective for emergency hyperkalemia treatment—no oral, intramuscular, subcutaneous, or endotracheal routes work for cardiac membrane stabilization. 2 IO access is equivalent to IV access and should be obtained immediately if peripheral IV attempts fail. 2
Central venous access is actually preferred over peripheral IV because it reduces the risk of severe tissue injury from extravasation, and calcium chloride (which is more potent) can be safely administered through central lines. 5, 2
Monitoring and Repeat Dosing
- Continuous ECG monitoring is mandatory during and for 5–10 minutes after calcium administration 1, 2, 3
- If no ECG improvement within 5–10 minutes, administer a second dose of 15–30 mL calcium gluconate IV over 2–5 minutes 1, 2
- Stop injection immediately if symptomatic bradycardia occurs or heart rate decreases by 10 beats per minute 2
- The cardioprotective effect begins within 1–3 minutes but lasts only 30–60 minutes, so concurrent potassium-lowering therapies must be initiated simultaneously 1, 4, 3
Critical Safety Considerations
Never administer calcium through the same IV line as sodium bicarbonate—precipitation of insoluble calcium salts will occur, compromising safety and efficacy. 1
In patients with tumor lysis syndrome or elevated serum phosphate, use calcium cautiously because the combination raises the risk of calcium-phosphate precipitation within tissues, leading to vascular and soft-tissue calcification. 1
For cardiac arrest suspected to be secondary to hyperkalemia, use calcium chloride 10 mL IV push rather than calcium gluconate, as it provides more rapid membrane stabilization. 4
Clinical Algorithm
- Verify hyperkalemia with ECG changes (peaked T waves, widened QRS, prolonged PR interval, arrhythmias) or K+ ≥6.5 mEq/L 1
- Do NOT delay calcium while waiting for repeat potassium levels if ECG changes are present—ECG changes indicate urgent need regardless of the exact potassium value 1
- Administer first dose: 15–30 mL of 10% calcium gluconate IV over 2–5 minutes 1, 2
- Monitor ECG continuously for 5–10 minutes 1, 2
- If no improvement, give second dose: 15–30 mL IV over 2–5 minutes 1, 2
- Simultaneously initiate potassium-lowering therapies (insulin + glucose, nebulized albuterol, sodium bicarbonate if acidotic) 1, 4
Common Pitfalls to Avoid
- Do not attempt oral calcium administration for acute hyperkalemia—it has no role in emergency cardiac membrane stabilization 2
- Do not delay calcium administration while attempting multiple peripheral IV sticks—move quickly to IO or central access 2
- Do not rely on calcium alone—it is a temporizing measure only, and failure to initiate concurrent potassium-lowering therapies will result in recurrent life-threatening arrhythmias within 30–60 minutes 1, 4
- Remember that calcium does NOT remove potassium from the body—it only temporarily protects the heart 1, 4, 3
Evidence Quality Note
While IV calcium is routinely recommended for severe hyperkalemia with ECG changes, the evidence supporting this practice is primarily observational and anecdotal rather than from randomized controlled trials. 3 One prospective study found calcium gluconate was effective in only 9 of 79 main rhythm disorders (11.4%), and showed no statistically significant benefit for non-rhythm ECG abnormalities. 3 However, given the life-threatening nature of severe hyperkalemia and the rapid onset of action (1–3 minutes), calcium remains the standard of care for immediate cardiac membrane stabilization while definitive potassium-lowering measures are implemented. 1, 4, 3, 6